Zhang et al. [49] found that IGF2BP2 targets and stabilizes serum response factor (SRF) mRNA, regulates osteogenic differentiation (OGD), and can be a potential marker and therapeutic target for osteoporosis and OGD. This evidence concerns the gene SRF and osteoporosis.